J. Loh

Most-cited papers

1. Hallmarks of cancer stemness.

   J. Loh, Stephianie Ma

   2024Cell Stem Cell313 citations

   Semantic Scholar

   Save

2. ADAR1-mediated RNA editing of SCD1 drives drug resistance and self-renewal in gastric cancer

   Tin-Lok Wong, J. Loh, Shixun Lu, Helen H. N. Yan +11 more

   2023Nature Communications113 citations Open access

   Semantic Scholar

   Save

3. FSTL1 Secreted by Activated Fibroblasts Promotes Hepatocellular Carcinoma Metastasis and Stemness

   J. Loh, Tsz-Wai Li, Lei Zhou, Tin-Lok Wong +8 more

   2021Cancer Research81 citations Open access

   Semantic Scholar

   Save

4. Long Noncoding RNA URB1-Antisense RNA 1 (AS1) Suppresses Sorafenib-Induced Ferroptosis in Hepatocellular Carcinoma by Driving Ferritin Phase Separation.

   Yuan Gao, M. Tong, Tin-Lok Wong, K. Ng +6 more

   2023ACS Nano78 citations

   Semantic Scholar

   Save

5. Molecular and in vivo Functions of the CDK8 and CDK19 Kinase Modules

   M. Dannappel, Dhanya Sooraj, J. Loh, R. Firestein

   2019Front. Cell Dev. Biol.70 citations Open access

   Semantic Scholar

   Save

6. The Role of Cancer-Associated Fibroblast as a Dynamic Player in Mediating Cancer Stemness in the Tumor Microenvironment

   J. Loh, Stephanie Ma

   2021Frontiers in Cell and Developmental Biology41 citations Open access

   Semantic Scholar

   Save

7. Targeting AXL induces tumor-intrinsic immunogenic response in tyrosine kinase inhibitor-resistant liver cancer

   Yu-Nong Xie, Haofeng Wu, Yi-Miao He, Linglin Liu +10 more

   2024Cell Death and Disease26 citations Open access

   Semantic Scholar

   Save

8. DGKH-mediated phosphatidic acid oncometabolism as a driver of self-renewal and therapy resistance in HCC.

   J. Loh, K. Ng, I. B. Huang, Mingdan Deng +11 more

   2024Hepatology10 citations

   Semantic Scholar

   Save

9. Abstract 1988: Mass spectrometry profiling identifies ENO2 as a driver of lenvatinib resistance in hepatocellular carcinoma

   Sukbum Kim, J. Loh, Hua-Jian Yu, Ki-Fong Man +4 more

   2024Cancer Research1 citations

   Semantic Scholar

   Save

10. Abstract 5447: Microtubule-associated protein MAP2 promotes drug resistance and cancer stemness in hepatocellular carcinoma through integrin dysregulation

    U. Lou, Ka-Hei Lam, Hua-Jian Yu, J. Loh +6 more

    2024Cancer Research1 citations Open access

    Semantic Scholar

    Save

11. Abstract 2208: MAP2-mediated integrin dysregulation reprograms cancer cell plasticity to drive liver cancer cell transition to a mesenchymal and stemness state in hepatocellular carcinoma.

    U. Lou, Tin-Lok Wong, Hua-Jian Yu, Ki-Fong Man +6 more

    2026Cancer Research0 citations

    Semantic Scholar

    Save

12. MAP2-mediated integrin dysregulation reprograms cancer cell plasticity in hepatocellular carcinoma

    U. Lou, Tin-Lok Wong, I. B. Huang, Ka-Hei Lam +7 more

    2026Nature Communications0 citations Open access

    Semantic Scholar

    Save

13. Abstract 5249: In vitro co-culture CRISPR screen identifies SMG1 to potentiate T cell-mediated cytotoxicity in hepatocellular carcinoma

    Ka-Hei Lam, Tin-Lok Wong, K. Ng, V. Tano +6 more

    2025Cancer Research0 citations

    Semantic Scholar

    Save

14. Abstract 1755: ADAR1-mediated RNA editing of SCD1 links lipid metabolism to gastric cancer drug resistance and self-renewal

    J. Loh, Tin-Lok Wong, Shixun Lu, Helen H. N. Yan +11 more

    2023Cancer Research0 citations

    Semantic Scholar

    Save

15. Abstract 395: Resistance to tyrosine kinase inhibitor confers an immunosuppressive microenvironment and cross-resistance to immunotherapy through AXL/PDPK1 axis in liver cancer

    Yu-Nong Xie, Bo-Sheng Huang, Huajian Yu, J. Loh +4 more

    2023Cancer Research0 citations

    Semantic Scholar

    Save

16. IDDF2022-ABS-0084 Adar1-mediated RNA editing of scd1 links lipid metabolism to drug resistance and self-renewal in gastric cancer

    J. Loh, Tin-Lok Wong, Shixun Lu, Helen H. N. Yan +10 more

    2022Basic Gastroenterology0 citations

    Semantic Scholar

    Save